Deep Vein Thrombosis and Pulmonary Embolism
Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE)
Deep vein thrombosis refers to a blood clot that develops in one of the body's deeper veins, most often in the legs. However, clots can also form in the arms or ovarian veins. If a portion of the clot dislodges and travels to the lungs, it can block the pulmonary artery, leading to a pulmonary embolism—a serious and potentially fatal condition.
Both DVT and PE require immediate medical attention to avoid severe complications.
Recognizing the Symptoms
These conditions present with distinct signs:
DVT Indicators:
- Swelling, typically in one leg
- Pain or soreness, especially in the calf
- Skin that feels warm or appears red
PE Indicators:
- Sudden difficulty breathing
- Sharp chest pain that worsens with inhalation
- Rapid heartbeat
- Dizziness or fainting
If you experience symptoms of PE, seek emergency care without delay.
Who Is at Risk for DVT?
Several factors can increase your chances of developing DVT:
- Extended periods of inactivity, such as long flights or bed rest
- Lack of proper hydration
- Inherited clotting disorders
- Use of certain medications, including hormone therapy or steroids
- Physical injury to the lower limbs
- Age—those over 60 are more susceptible
Diagnostic Tools
To confirm DVT or PE, healthcare providers may use:
- Ultrasound imaging to locate clots in the legs
- D-dimer blood tests to assess clotting levels
- Chest CT scans to identify clots in the lungs
- Specialized scans like venography or lung perfusion tests
Early detection is essential to prevent serious outcomes.
Treatment Options and Ongoing Care
Managing DVT and PE typically involves:
- Anticoagulants to stop clots from enlarging
- Compression garments to ease swelling
- Clot-busting medications in critical cases
- Lifestyle adjustments, such as regular movement and hydration
In some cases, newer clots can be removed directly. Chronic clots may require procedures to reopen veins and restore circulation, helping to reduce pain and swelling.
Ongoing follow-up is crucial to minimize the risk of recurrence.